# Jonathan Smiga

> Jonathan Smiga is a Series A investor at KEEN Growth Capital backing Wellness and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [KEEN Growth Capital](https://shizune.co/investors/profile/keen-growth-capital)
- Location: Orlando, United States
- Total investments: 2
- Last investment: Sep 2021
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/jonathan-smiga-283b963/

Jonathan Smiga is a Series A investor at KEEN Growth Capital in Orlando focused on Wellness and Health Care. Jonathan Smiga is the Managing Partner at KEEN Growth Capital. He attended Cornell University and NYU Stern School of Business.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Wellness | 1 | 50% |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Food and Beverage | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Venture - Series Unknown | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Healthycell | Healthycell is based on the simple idea that nutrients need to be absorbed into the bloodstream and then into cells where they work to improve health. But most supplements use the same pill-form delivery technologies that were around in the 1930's, back when we were using rotary phones! Our nutrient delivery technologies have not kept pacewith the innovation of other industries. Decades of lab work show that most pills (and even powders) have low absorption. These older delivery systems compress dehydrated, large, dense, insoluble particles that are 10x to 100x too big for absorption through the small intestine where the human body absorbs most nutrients. That's why we forced the evolution of nutrition supplements with MICROGEL™. | $1.6M | Series A | Sep 14, 2021 |  |
| Healthycell | Healthycell is based on the simple idea that nutrients need to be absorbed into the bloodstream and then into cells where they work to improve health. But most supplements use the same pill-form delivery technologies that were around in the 1930's, back when we were using rotary phones! Our nutrient delivery technologies have not kept pacewith the innovation of other industries. Decades of lab work show that most pills (and even powders) have low absorption. These older delivery systems compress dehydrated, large, dense, insoluble particles that are 10x to 100x too big for absorption through the small intestine where the human body absorbs most nutrients. That's why we forced the evolution of nutrition supplements with MICROGEL™. | $1.6M | Venture - Series Unknown | Sep 14, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [Balanced Breakfast](https://shizune.co/investors/profile/balanced-breakfast) — VC Fund, 2 deals together

## About KEEN Growth Capital

VC Fund · Windermere, United States

KEEN paves the way for early stage impact brands to flourish. KEEN Growth Capital identifies food, beverage and wellness companies with great potential started by revolutionary-thinking, passionate entrepreneurs. The firm applies trusted skill and passion to develop portfolio brands into highly successful and respected companies. Infusion ofintellectual and financial capital delivers positive outcomes for stakeholders - and ultimately the consumer. Investors benefit from outstanding returns and society is enriched by healthier products.

5 contacts available at KEEN Growth Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Jonathan Smiga | Managing Partner | https://shizune.co/investors/profile/jonathan-smiga |
| David Comeau | Venture Partner | https://shizune.co/investors/profile/david-comeau |
| Donna Spence | CFO | https://shizune.co/investors/profile/donna-spence |
| Jerry Bello | Co-Founder, Managing Partner & CEO | https://shizune.co/investors/profile/jerry-bello |
| Robert Althuis | Venture Partner | https://shizune.co/investors/profile/robert-althuis |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Jonathan Smiga invest in?

Jonathan Smiga invests primarily in Wellness, Health Care and Biotechnology startups, most often at Series A and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jonathan Smiga last invest?

The most recent investment recorded for Jonathan Smiga closed in Sep 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co